AKT and p70 S6 kinase inhibitors

Details for Australian Patent Application No. 2009314324 (hide)

Owner Eli Lilly and Company

Inventors Dally, Robert Dean; Joseph, Sajan; Shepherd, Timothy Alan

Agent Spruson & Ferguson

Pub. Number AU-A-2009314324

PCT Pub. Number WO2010/056563

Priority 61/113,273 11.11.08 US

Filing date 3 November 2009

Wipo publication date 20 May 2010

International Classifications

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056563 Priority application(s): WO2010/056563

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314335-P70 S6 kinase inhibitor and mTOR inhibitor combination therapy

2009314323-Card reading shoe with inventory correction feature and methods of correcting inventory